Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 7/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | PARL | Q9H300 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 3/20 | 0.40 |
| ▸ | MET | P08581 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28904396 | 0.83 | CA1 (0.49) | HTTALDH1A1PKML3MBTL1MMP2 | |
| SCHEMBL28988635 | 0.79 | ALDH3A1 (0.42) | HTR6MEN1KMT2AHTTLMNA | |
| SCHEMBL29050048 | 0.77 | AKR1C3 (0.40) | AKR1C3AKR1C1HTR6MEN1KMT2A | |
| SCHEMBL21805760 | 0.72 | AKR1C3 (0.49) | AKR1C3AKR1C1HTR6MEN1KMT2A | |
| SCHEMBL23158886 | 0.71 | KMT2A (0.53) | AKR1C3AKR1C1HTR6MEN1KMT2A | |
| SCHEMBL28139909 | 0.71 | PPME1 (0.51) | HTR6MEN1KMT2AHTTLMNA | |
| SCHEMBL20534977 | 0.70 | RAPGEF4 (0.48) | KMT2AHTTLMNAALDH1A1HPGD | |
| SCHEMBL1043519 | 0.69 | BRD4 (0.58) | AKR1C3AKR1C1HTR6MEN1KMT2A | |
| SCHEMBL29065520 | 0.69 | HTR6 (0.47) | AKR1C3AKR1C1HTR6MEN1KMT2A | |
| SCHEMBL13341561 | 0.69 | MET (0.40) | AKR1C3AKR1C1HTR6MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137698-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | JOINT STOCK CO «BIOCAD» (RU) | 2026-05-21 | — | — | US | disclosed |
| EP-4592283-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | Joint Stock Company "Biocad" (RU) | 2025-07-30 | — | — | EP | disclosed |
| WO-2024063670-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | Акционерное общество "БИОКАД" | 2024-03-28 | — | — | WO | disclosed |
| CN-117580592-A | Compounds for targeting bruton's tyrosine kinase degradation | 渤健马萨诸塞州股份有限公司 | 2024-02-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137698-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | CDK7, CDK6, CDK3 | AKR1C3 1761/4885AKR1C1 2176/4885HTR6 1580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.